[Effect of alloxan diabetes in staphylococcal infection in mice].
D000818:Animals; D001966:Bromine / Q000494:pharmacology; D003921:Diabetes Mellitus, Experimental / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D005260:Female; D007109:Immunity / Q000187:drug effects; D007114:Immunization; D007165:Immunosuppression Therapy; D008297:Male; D008353:Mannitol / Q000031:analogs & derivatives / Q000494:pharmacology; D008357:Mannomustine / Q000494:pharmacology; D051379:Mice; D008807:Mice, Inbred BALB C; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000209:etiology / Q000276:immunology*; D013210:Staphylococcus / Q000276:immunology / Q000472:pathogenicity; D013997:Time Factors; D014774:Virulence
D008353:Mannitol; D008357:Mannomustine; D001966:Bromine
Vliianie alloksanovogo diabeta na stafilokokkovuiu infektsiiu u mysheĭ.